Voyager Therapeutics Inc (STU:VT6)
€ 7.49 0.255 (3.52%) Market Cap: 411.54 Mil Enterprise Value: 83.09 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 59/100

Q3 2023 Voyager Therapeutics Inc Earnings Call Transcript

Nov 06, 2023 / 09:30PM GMT
Release Date Price: €6.1 (-2.40%)
Operator

Good afternoon, and welcome to the Voyager Therapeutics Third Quarter 2023 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. A replay of today's call will be available on the Investors section of the company's website approximately 2 hours after completion of this call. I would now like to turn the call over to Pete Pfreundschuh, Chief Financial Officer. You may begin.

Peter P. Pfreundschuh
Voyager Therapeutics, Inc. - CFO

Thank you, and good afternoon. Joining me on the call today is Dr. Al Sandrock, our CEO. And joining us for Q&A is Dr. Todd Carter, our Chief Scientific Officer. We issued our Q3 2023 financial results press release this afternoon. The press release and 10-Q are available on our website.

In a moment, I will turn the call over to Al. Before I do this, I want to remind everyone that during the call, Voyager representatives may make forward-looking statements as noted in Slide 2 of today's deck. These forward-looking statements include future expectations,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot